Acorda Therapeutics Announces Pricing Of Initial Public Offering

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Feb. 10, 2006--Acorda Therapeutics (Nasdaq: ACOR) announced today the initial public offering of 5,500,000 shares of common stock at a price of $6.00 per share. All of the shares are being offered by Acorda Therapeutics. Acorda’s common stock will begin trading today on The NASDAQ National Market under the symbol “ACOR.”

MORE ON THIS TOPIC